Asensus Surgical Inc (AMEX:ASXC) finished Wednesday with an addition of $0.02 to close at $0.28, an upside of 11.13 percent. An average of 1,519,820 shares of common stock have been traded in the last five days. There was a fall of -$0.0029 in the past week, and it reached a new high 8 times over the past 12 months. The last 20 days have seen an average of 4,701,570 shares traded, while the 50-day average volume stands at 3,367,032.
ASXC stock has increased by 1.64% in the last month. The company shares reached their 1-month lowest point of $0.2504 on 09/26/23. With the stock rallying to its 52-week high on 02/21/23, shares of the company touched a low of $0.25 and a high of $1.18 in 52 weeks. It has reached a new high 12 times so far this year and lost -18.01% or -$0.0625 in price. In spite of this, the price is down -75.88% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Asensus Surgical Inc (ASXC) stock’s beta is 1.64. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 10.61, the price-to-book (PB) ratio at 1.11.
Financial Health
The quick ratio of Asensus Surgical Inc for the three months ended June 29 was 4.30, and the current ratio was 5.16, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.08 and a total debt to equity ratio of 0.09 for the quarter ending June 29. Asensus Surgical Inc’s EBITDA margin for the year ending June 29 is -907.11%, while its operating margin for the same period stands at -1121.20%. Its gross profit as reported stood at -$3.79 million compared to revenue of $7.09 million.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$20.66 million in the quarter, while revenues of -$22.22 million were grew 5.03%. The analyst consensus anticipated Asensus Surgical Inc’s latest quarter earnings to come in at -$0.08 per share, but it turned out to be -$0.09, a -12.50% surprise. For the quarter, EBITDA amounted to -$20.12 million. Shareholders own equity worth $263.88 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Asensus Surgical Inc (ASXC) price momentum. RSI 9-day as of the close on 27 September was 48.75%, suggesting the stock is Neutral, with historical volatility in this time frame at 83.77%.
As of today, ASXC’s price is $0.2697 -1.01% or -$0.0029 from its 5-day moving average. ASXC is currently trading -4.27% lower than its 20-day SMA and -54.10% lower than its 100-day SMA. However, the stock’s current price level is -53.29% below the SMA50 and -27.84% below the SMA200.
The stochastic %K and %D were 13.76% and 8.27%, respectively, and the average true range (ATR) was 0.0260. With the 14-day stochastic at 36.15% and the average true range at 0.0284, the RSI (14) stands at 45.63%. The stock has reached -0.0092 on the 9-day MACD Oscillator while the 14-day reading was at -0.0218.
Analyst Ratings
Cantor Fitzgerald launched coverage on Asensus Surgical Inc (AMEX: ASXC) in its analyst report released on September 08, 2022. The firm assigned the stock an Overweight rating. The consensus rating for Asensus Surgical Inc (ASXC) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ASXC, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.
What is ASXC’s price target for the next 12 months?
Analysts predict a range of price targets between $1.00 and $2.00, with a median target of $1.50. Taking a look at these predictions, the average price target given by analysts for Asensus Surgical Inc (ASXC) stock is $1.50.
